FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:80-82 July 3, 2003 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Tallman, M. S. Related Article by Rodenhuis, S. PubMed Citation

The controversy over the question of whether to use high-dose chemotherapy and autologous hematopoietic stem-cell transplantation in women with high-risk breast cancer has persisted for more than a decade.¹ It has never been more clearly highlighted than it is in the articles by Rodenhuis² and Tallman³ and their colleagues in this issue of the Journal. Rodenhuis et al. conclude that "high-dose alkylating therapy improves relapse-free survival among patients with stage II or III breast cancer and 10 or more positive axillary lymph nodes," whereas Tallman et al. conclude that "the addition of high-dose chemotherapy and autologous hematopoietic stem-cell transplantation . . . [Full Text of this Article]

Source Information

From Roger Williams Medical Center, Providence, R.I.

Related Letters:

High-Dose Chemotherapy for Breast Cancer
Wheatley K., Gray R. G., Ives N. J., Tartarone A., Iodice G., Di Renzo N., Mangano M. M., Dazzi C., Cariello A., Rodenhuis S., van Tinteren H., de Vries E. G.E., Tallman M. S., Robert N. J., Lazarus H. M., Elfenbein G. J.
Extract | Full Text | PDF  
N Engl J Med 2003; 349:1476-1479, Oct 9, 2003. Correspondence

This article has been cited by other articles:

• Cachin, F., Prince, H. M., Hogg, A., Ware, R. E., Hicks, R. J. (2006). Powerful Prognostic Stratification By [18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy. JCO 24: 3026-3031 [Abstract] [Full Text]  
• Nieboer, P., Buijs, C., Rodenhuis, S., Seynaeve, C., Beex, L. V.A.M., van der Wall, E., Richel, D. J., Nooij, M. A., Voest, E. E., Hupperets, P., Mulder, N. H., van der Graaf, W. T.A., TenVergert, E. M., van Tinteren, H., de Vries, E. G.E. (2005). Fatigue and Relating Factors in High-Risk Breast Cancer Patients Treated With Adjuvant Standard or High-Dose Chemotherapy: A Longitudinal Study. JCO 23: 8296-8304 [Abstract] [Full Text]  
• Andre, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., Tabah-Fisch, I., de Gramont, A., the Multicenter International Study of Oxaliplatin, (2004). Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer. NEJM 350: 2343-2351 [Abstract] [Full Text]  
• Gratwohl, A., Baldomero, H., Demirer, T., Rosti, G., Dini, G., Ladenstein, R., Urbano-Ispizua, A. (2004). Hematopoetic stem cell transplantation for solid tumors in Europe. Ann Oncol 15: 653-660 [Abstract] [Full Text]  
• Wheatley, K., Gray, R. G., Ives, N. J., Tartarone, A., Iodice, G., Di Renzo, N., Mangano, M. M., Dazzi, C., Cariello, A., Rodenhuis, S., van Tinteren, H., de Vries, E. G.E., Tallman, M. S., Robert, N. J., Lazarus, H. M., Elfenbein, G. J. (2003). High-Dose Chemotherapy for Breast Cancer. NEJM 349: 1476-1479 [Full Text]  
• (2003). High-Dose Chemo with Stem-Cell Rescue for High-Risk Breast Cancer?. JWatch Women's Health 2003: 4-4 [Full Text]  
• (2003). High-Dose Chemotherapy Plus Stem-Cell Rescue in High-Risk Breast Cancer. JWatch General 2003: 1-1 [Full Text]